US Patent 10738117 Antibodies directed against programmed death-1 (PD-1)
Patent 10738117 was granted and assigned to AnaptysBio on August, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 5, 2017
0
Date of Patent
August 11, 2020
0
Patent Applicant
Patent Application Number
15726287
0
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10738117 Antibodies directed against programmed death-1 (PD-1)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.